Investment Rating - The report maintains an "Outperform" rating for the company [4][7]. Core Views - The company reported a revenue of 806 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 4.2%. However, the net profit attributable to the parent company decreased by 77.7% to 15 million yuan [3][5]. - In Q3 2025, the company experienced a revenue decline of 8.7% to 244 million yuan, with a net loss of 590,000 yuan, indicating a shift from profit to loss [3][5]. - The company is focusing on expanding its product offerings in the sports nutrition sector, with new product launches aimed at maintaining market competitiveness [6][7]. Financial Data and Profit Forecast - The total revenue forecast for 2025 is adjusted to 1.192 billion yuan, with a year-on-year growth rate of 14.6%. The net profit forecast is revised down to 65 million yuan, reflecting a decrease of 26.8% [5][7]. - The projected earnings per share for 2025 is 0.53 yuan, with a gross margin of 33.8% [5][7]. - The company is expected to maintain a compound annual growth rate (CAGR) of 22% in revenue from 2025 to 2027, despite short-term pressures on gross margins due to high raw material prices [7][8].
康比特（920429）：Q3收入承压但毛利率企稳，上市新品丰富成长动能